Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Coffey, S., Cox, B. & Williams, M. J. A. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: Increasing deaths and minimal change in mortality rate over the past three decades. Am. Heart J. 167, 562–567 (2014).
2. Hammermeister, K. et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the veterans affairs randomized trial. J. Am. Coll. Cardiol. 36, 1152–1158 (2000).
3. Jayakrishnan, A. & Jameela, S. R. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 17, 471–484 (1996).
4. Nachlas, A. L. Y., Li, S. & Davis, M. E. Developing a clinically relevant tissue engineered heart valve-A review of current approaches. Adv. Healthc. Mater. 6, 1700918 (2017).
5. Cebotari, S. et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114, I132–I137 (2006).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献